• Discounts and special offers
  • Subscriber-only articles and interviews
  • Breaking news and trending topics

Already a subscriber?

By signing up, you accept Moneywise's Terms of Use, Subscription Agreement, and Privacy Policy.

Not interested ?

Cuts without care

On April 1, thousands of employees at the Department of Health and Human Services (HHS) were laid off as part of a policy targeting 10,000 agency-wide jobs. The cuts hit agencies like the FDA, CDC and NIH — the same institutions responsible for overseeing everything from prenatal research to postpartum support.

One former employee told Politico she had carpooled into the office that morning, only to find herself locked out.

“We got completely blindsided this morning,” the staffer told Politico. “People were already on the way to the office when they found out.”

The Trump administration defended the measures, describing them as necessary steps towards streamlining an inefficient bureaucracy. Health Secretary Robert F. Kennedy Jr. emphasized that the goal is to eliminate redundant programs, which the HHS is expected to save $1.8 billion annually.

However, the cuts are being felt nationwide, with studies on maternal health being abandoned. Columbia University’s NY-CHAMP Center of Excellence program planned to enroll 600 participants for 2025, but was only able to fund 21. That was only after they secured private funding due to government funds being frozen. It’s too soon — and the sample size is too small — to tell how much of an impact the loss of funding will have on CHAMP’s studies.

Invest in real estate without the headache of being a landlord

Imagine owning a portfolio of thousands of well-managed single family rentals or a collection of cutting-edge industrial warehouses. You can now gain access to a $1B portfolio of income-producing real estate assets designed to deliver long-term growth from the comforts of your couch.

The best part? You don’t have to be a millionaire and can start investing in minutes.

Learn More

The billion-dollar question

As DOGE cuts funding for maternal care, advocates argue the case for women’s health isn’t just moral — it’s economic.

A study by Women’s Health Access Matters found that $300 million in research across three major diseases could generate $13 billion in economic returns. Experts say government-backed research often lays the foundation for private-sector breakthroughs. Right now, that foundation is cracking.

“Women’s health research is not being invested in at the level of the private sector, " said Lindsey Miltenberger, the chief advocacy officer at the Society for Women’s Health Research. “Making sure that is prioritized in the federal government is really important for creating that foundational research that can then be picked up by the private sector and commercialized.”

Dr. Uma Reddy, who led the now-underfunded NY-CHAMP study, said her team’s interventions likely saved the government money by helping women avoid serious and costly health crises.

“We can address this,” Reddy told Politico. “We can improve maternal health by preventing these mental health conditions, complications … and improve families and children’s lives, and it’s cost-effective.”

Sponsored

Meet your retirement goals effortlessly

The road to retirement may seem long, but with Advisor, you can find a trusted partner to guide you every step of the way

Advisor matches you with vetted financial advisors that offer personalized advice to help you to make the right choices, invest wisely, and secure the retirement you've always dreamed of. Start planning early, and get your retirement mapped out today.

Victoria Vesovski Staff Reporter

Victoria Vesovski is a Staff Reporter for Moneywise currently pursuing her Masters of Journalism at New York University.

Disclaimer

The content provided on Moneywise is information to help users become financially literate. It is neither tax nor legal advice, is not intended to be relied upon as a forecast, research or investment advice, and is not a recommendation, offer or solicitation to buy or sell any securities or to adopt any investment strategy. Tax, investment and all other decisions should be made, as appropriate, only with guidance from a qualified professional. We make no representation or warranty of any kind, either express or implied, with respect to the data provided, the timeliness thereof, the results to be obtained by the use thereof or any other matter. Advertisers are not responsible for the content of this site, including any editorials or reviews that may appear on this site. For complete and current information on any advertiser product, please visit their website.

†Terms and Conditions apply.